These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 29601139)

  • 41. Endogenous contrast T1rho cardiac magnetic resonance for myocardial fibrosis in hypertrophic cardiomyopathy patients.
    Wang C; Zheng J; Sun J; Wang Y; Xia R; Yin Q; Chen W; Xu Z; Liao J; Zhang B; Gao F
    J Cardiol; 2015 Dec; 66(6):520-6. PubMed ID: 25981868
    [TBL] [Abstract][Full Text] [Related]  

  • 42. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique.
    White SK; Sado DM; Fontana M; Banypersad SM; Maestrini V; Flett AS; Piechnik SK; Robson MD; Hausenloy DJ; Sheikh AM; Hawkins PN; Moon JC
    JACC Cardiovasc Imaging; 2013 Sep; 6(9):955-62. PubMed ID: 23582361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myocardial extracellular volume fraction measurements with MOLLI 5(3)3 by cardiovascular MRI for the discrimination of healthy volunteers from dilated and hypertrophic cardiomyopathy patients.
    Cui Y; Chen Y; Cao Y; Liu J; Song J; Zhang S; Kong X; Han P; Shi H
    Clin Radiol; 2019 Sep; 74(9):732.e9-732.e16. PubMed ID: 31122714
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Noninvasive assessment of myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy.
    Almaas VM; Haugaa KH; Strøm EH; Scott H; Smith HJ; Dahl CP; Geiran OR; Endresen K; Aakhus S; Amlie JP; Edvardsen T
    Heart; 2014 Apr; 100(8):631-8. PubMed ID: 24368281
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Significance of Interstitial Fibrosis on Left Ventricular Function in Hypertensive versus Hypertrophic Cardiomyopathy.
    Jiang M; Wang Z; Su X; Gong X; Pu J; Wu L; Liu C; Yao Q; Kong L; Xu J; He B
    Sci Rep; 2018 Jul; 8(1):9995. PubMed ID: 29968754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.
    Collins J; Sommerville C; Magrath P; Spottiswoode B; Freed BH; Benzuly KH; Gordon R; Vidula H; Lee DC; Yancy C; Carr J; Markl M
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552491
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience.
    Kellman P; Wilson JR; Xue H; Bandettini WP; Shanbhag SM; Druey KM; Ugander M; Arai AE
    J Cardiovasc Magn Reson; 2012 Sep; 14(1):64. PubMed ID: 22967246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy.
    Haland TF; Almaas VM; Hasselberg NE; Saberniak J; Leren IS; Hopp E; Edvardsen T; Haugaa KH
    Eur Heart J Cardiovasc Imaging; 2016 Jun; 17(6):613-21. PubMed ID: 26873460
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 4D flow MRI and T1 -Mapping: Assessment of altered cardiac hemodynamics and extracellular volume fraction in hypertrophic cardiomyopathy.
    van Ooij P; Allen BD; Contaldi C; Garcia J; Collins J; Carr J; Choudhury L; Bonow RO; Barker AJ; Markl M
    J Magn Reson Imaging; 2016 Jan; 43(1):107-14. PubMed ID: 26227419
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The diagnostic value of multiparameter cardiovascular magnetic resonance for early detection of light-chain amyloidosis from hypertrophic cardiomyopathy patients.
    Yue X; Yang L; Wang R; Chan Q; Yang Y; Wu X; Ruan X; Zhang Z; Wei Y; Wang F
    Front Cardiovasc Med; 2022; 9():1017097. PubMed ID: 36330005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The association between cardiac mr feature tracking strain and myocardial late gadolinium enhancement in patients with hypertrophic cardiomyopathy].
    Ozden O; Unlu S; Kilic DI; Sherif SA; Opan S; Kemal HS; Ozmen E; Tuner H; Bingol G; Barutcu A; Nasifov M; Bakan S; Goktekin O
    Kardiologiia; 2023 Feb; 63(2):52-58. PubMed ID: 36880144
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increase in skeletal muscle extracellular volume as an under-recognised change detected at cardiac MRI in hypertrophic cardiomyopathy.
    Xu P; Liu W; Qian W; Wang J; Wang Y; Zhou X; Zhu Y; Xu Y; Zhu X
    Clin Radiol; 2023 May; 78(5):e401-e408. PubMed ID: 36890013
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduced myocardial septal function assessed by cardiac magnetic resonance feature tracking in patients with hypertrophic obstructive cardiomyopathy: associated with histological myocardial fibrosis and ventricular arrhythmias.
    Song Y; Bi X; Chen L; Yang K; Chen X; Dong Z; Wang J; Kong X; Zhao K; Wang H; Duru F; Lu M; Ma L; Qiao S; Zhao S
    Eur Heart J Cardiovasc Imaging; 2022 Jul; 23(8):1006-1015. PubMed ID: 35167663
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation the relationship between myocardial fibrosis and left ventricular torsion measured by cardiac magnetic resonance feature-tracking in hypertrophic cardiomyopathy patients with preserved ejection fraction.
    Zhong Y; Li C; Yu Y; Du Y; Bai Y; Wang X; Dai X; Fan G; Wang G
    Int J Cardiovasc Imaging; 2024 Apr; 40(4):921-930. PubMed ID: 38448705
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prediction of the estimated 5-year risk of sudden cardiac death and syncope or non-sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy using late gadolinium enhancement and extracellular volume CMR.
    Avanesov M; Münch J; Weinrich J; Well L; Säring D; Stehning C; Tahir E; Bohnen S; Radunski UK; Muellerleile K; Adam G; Patten M; Lund G
    Eur Radiol; 2017 Dec; 27(12):5136-5145. PubMed ID: 28616729
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comprehensive evaluation of macroscopic and microscopic myocardial fibrosis by cardiac MR: intra-individual comparison of gadobutrol versus gadoterate meglumine.
    Rahsepar AA; Ghasemiesfe A; Suwa K; Dolan RS; Shehata ML; Korell MJ; Naresh NK; Markl M; Collins JD; Carr JC
    Eur Radiol; 2019 Aug; 29(8):4357-4367. PubMed ID: 30617490
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
    Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
    Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improved segmental myocardial strain reproducibility using deformable registration algorithms compared with feature tracking cardiac MRI and speckle tracking echocardiography.
    Wang J; Li W; Sun J; Liu H; Kang Y; Yang D; Yu L; Greiser A; Zhou X; Han Y; Chen Y
    J Magn Reson Imaging; 2018 Aug; 48(2):404-414. PubMed ID: 29283466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.